| Sample | Title | Value | Rank |
|---|
| GSM780707 | Untreated after 4 days (C1_1) | 72.7102 | 70 |
| GSM780708 | Untreated after 4 days (C2_1) | 71.9294 | 70 |
| GSM780709 | Untreated after 4 days (C3_1) | 77.2256 | 71 |
| GSM780719 | Untreated after 4 days (C1_2) | 72.2089 | 70 |
| GSM780720 | Untreated after 4 days (C2_2) | 70.6979 | 69 |
| GSM780721 | Untreated after 4 days (C3_2) | 85.5217 | 73 |
| GSM780710 | Trastuzumab treated after 4 days (T1_1) | 67.4666 | 68 |
| GSM780711 | Trastuzumab treated after 4 days (T2_1) | 77.3306 | 71 |
| GSM780712 | Trastuzumab treated after 4 days (T3_1) | 61.8619 | 66 |
| GSM780722 | Trastuzumab treated after 4 days (T1_2) | 74.0848 | 70 |
| GSM780723 | Trastuzumab treated after 4 days (T2_2) | 80.2194 | 72 |
| GSM780724 | Trastuzumab treated after 4 days (T3_2) | 69.6702 | 69 |
| GSM780713 | Pertuzumab treated after 4 days (P1_1) | 73.0284 | 70 |
| GSM780714 | Pertuzumab treated after 4 days (P2_1) | 75.6019 | 71 |
| GSM780715 | Pertuzumab treated after 4 days (P3_1) | 70.7226 | 69 |
| GSM780725 | Pertuzumab treated after 4 days (P1_2) | 79.0278 | 71 |
| GSM780726 | Pertuzumab treated after 4 days (P2_2) | 71.548 | 69 |
| GSM780727 | Pertuzumab treated after 4 days (P3_2) | 69.2097 | 69 |
| GSM780716 | Trastuzumab and Pertuzumab treated after 4 days (TP1_1) | 81.4185 | 72 |
| GSM780717 | Trastuzumab and Pertuzumab treated after 4 days (TP2_1) | 70.5451 | 69 |
| GSM780718 | Trastuzumab and Pertuzumab treated after 4 days (TP3_1) | 65.435 | 67 |
| GSM780728 | Trastuzumab and Pertuzumab treated after 4 days (TP1_2) | 64.72 | 67 |
| GSM780729 | Trastuzumab and Pertuzumab treated after 4 days (TP2_2) | 69.9894 | 69 |